CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The novel endocannabinoid noladin ether holds putative anti-fibrotic properties by selectively inducing cell death in hepatic stellate cells
DOI 10.1055/s-0032-1331948
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Schlosser, A Wojtalla, FA Schildberg, PA Knolle, MV Singer, T Sauerbruch, A Zimmer, SV Siegmund
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: We could previously demonstrate that the endogenous cannabinoid 2-arachidonoyl glycerol (2-AG) is an antifibrotic lipid mediator that blocks proliferation and induces apoptotic cell death in hepatic stellate cells (HSCs), but not in hepatocytes. Recently a novel endocannabinoid termed noladin ether (NE, 2-arachidonyl glyceryl ether) has been identified, which represents a more stable entity against enzym…
Zitieren
Zitierempfehlung
M Schlosser, A Wojtalla, FA Schildberg, PA Knolle, MV Singer, T Sauerbruch, A Zimmer, SV Siegmund (2013) The novel endocannabinoid noladin ether holds putative anti-fibrotic properties by selectively inducing cell death in hepatic stellate cells. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0032-1331948
Mit CareLit weiterarbeiten